Kwak Tae Hwan, Hali Sai, Kim Sungmin, Kim Jonghun, La Hyeonwoo, Kim Kee-Pyo, Hong Kwon Ho, Shin Chan Young, Kim Nam-Hyung, Han Dong Wook
Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Korea.
Department of Neuroscience, School of Medicine and Center for Neuroscience Research, Konkuk University, Seoul, Korea.
Int J Stem Cells. 2020 Mar 30;13(1):80-92. doi: 10.15283/ijsc19097.
Recent studies have described direct reprogramming of mouse and human somatic cells into induced neural stem cells (iNSCs) using various combinations of transcription factors. Although iNSC technology holds a great potential for clinical applications, the low conversion efficiency and limited reproducibility of iNSC generation hinder its further translation into the clinic, strongly suggesting the necessity of highly reproducible method for human iNSCs (hiNSCs). Thus, in orderto develop a highly efficient and reproducible protocol for hiNSC generation, we revisited the reprogramming potentials of previously reported hiNSC reprogramming cocktails by comparing the reprogramming efficiency of distinct factor combinations including ours.
We introduced distinct factor combinations, OSKM (+++), alone, alone, +, ++ (BSKM), SK, SM, and SKM and performed comparative analysis of reprogramming potentials of distinct factor combinations in hiNSC generation.
Here we show that ectopic expression of five reprogramming factors, BSKM leads the robust hiNSC generation (>80 folds enhanced efficiency) from human somatic cells compared with previously described factor combinations. With our combination, we were able to observe hiNSC conversion within 7 days of transduction. Throughout further optimization steps, we found that both BRN4 and KLF4 are not essential for hiNSC conversion.
Our factor combination could robustly and reproducibly generate hiNSCs from human somatic cells with distinct origins. Therefore, our novel reprogramming strategy might serve as a useful tool for hiNSC-based clinical application.
最近的研究描述了使用多种转录因子组合将小鼠和人类体细胞直接重编程为诱导神经干细胞(iNSC)。尽管iNSC技术在临床应用方面具有巨大潜力,但iNSC生成的低转化效率和有限的可重复性阻碍了其进一步转化为临床应用,这强烈表明需要一种高度可重复的人类iNSC(hiNSC)生成方法。因此,为了开发一种高效且可重复的hiNSC生成方案,我们通过比较包括我们自己的不同因子组合的重编程效率,重新审视了先前报道的hiNSC重编程鸡尾酒的重编程潜力。
我们引入了不同的因子组合,单独的OSKM(+++)、单独的、单独的、+、++(BSKM)、SK、SM和SKM,并对hiNSC生成中不同因子组合的重编程潜力进行了比较分析。
我们发现,与先前描述的因子组合相比,异位表达五种重编程因子BSKM可使人体细胞高效生成hiNSC(效率提高>80倍)。使用我们的组合,我们能够在转导后7天内观察到hiNSC的转化。在进一步的优化步骤中,我们发现BRN4和KLF4对于hiNSC转化并非必需。
我们的因子组合能够可靠且可重复地从不同来源的人类体细胞中生成hiNSC。因此,我们的新型重编程策略可能成为基于hiNSC的临床应用的有用工具。